Autres langues EXACT Therapeutics

Actions

EXTX

NO0010852213

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
6,8 ^NOK	0,00 %		-2,86 %	-43,33 %

19/04	EXACT Therapeutics AS publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	EXACT Therapeutics AS publie ses résultats pour le semestre clos le 30 juin 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

EXACT Therapeutics : Successful placement of NOK 25 million share issue	25/04
EXACT Therapeutics AS Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Additional promising clinical data from EXACT Therapeutics' ongoing ACTIVATE study presented at AACR Annual Meeting	10/04
EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting	06/03
EXACT Therapeutics AS - Share capital increase registered	20/12
EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14	14/12
EXACT Therapeutics : announces successful placement of NOK 25 million share issue	01/12
EXACT Therapeutics AS: Primary insider notices	01/12
EXACT Therapeutics AS: Private placement successfully placed	30/11
EXACT Therapeutics AS: Contemplated Private Placement	30/11
Exact Therapeutics Wins Regulatory Approvals for Patient Recruitment in Dose Expansion Study	31/10/23
EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital	31/10/23
EXACT Therapeutics AS - Issuance of share options	16/10/23
EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel	12/10/23
EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2023	28/09/23
EXACT Therapeutics : Interim Report 2023	28/09/23
EXACT Therapeutics announces first half 2023 interim results	28/09/23
EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development	27/09/23
EXACT Therapeutics AS Announces Appointment of Caspar Foghsgaard as SVP Commercial & Business Development Effective 1 November 2023	27/09/23
Exact Therapeutics Jumps 13% After Positive Outcomes From Acoustic Cluster Therapy Trial	26/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues EXACT Therapeutics

Actions

EXTX

NO0010852213

Autres langues

Filtres